Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 18
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Metabolic rewiring induced by ranolazine improves melanoma responses to targeted therapy and immunotherapy

  • Redondo Muñoz, Marta
  • Heyn, Holger
  • Arozarena, Imanol
Resistance of melanoma to targeted therapy and immunotherapy is linked to metabolic rewiring. Here, we show that increased fatty acid oxidation (FAO) during prolonged BRAF inhibitor (BRAFi) treatment contributes to acquired therapy resistance in mice. Targeting FAO using the US Food and Drug Administration-approved and European Medicines Agency-approved anti-anginal drug ranolazine (RANO) delays tumour recurrence with acquired BRAFi resistance. Single-cell RNA-sequencing analysis reveals that RANO diminishes the abundance of the therapy-resistant NGFRhi neural crest stem cell subpopulation. Moreover, by rewiring the methionine salvage pathway, RANO enhances melanoma immunogenicity through increased antigen presentation and interferon signalling. Combination of RANO with anti-PD-L1 antibodies strongly improves survival by increasing antitumour immune responses. Altogether, we show that RANO increases the efficacy of targeted melanoma therapy through its effects on FAO and the methionine salvage pathway. Importantly, our study suggests that RANO could sensitize BRAFi-resistant tumours to immunotherapy. Since RANO has very mild side-effects, it might constitute a therapeutic option to improve the two main strategies currently used to treat metastatic melanoma., I.A., P.A., D.E. and A.M. acknowledge funding from the Ministry of Economy and Competitiveness (Institute of Health Carlos III; refs. PI19/00645 to I.A., PI16-01911 to I.A., CPII20/00011 to I.A., CD21/00137 to P.A., PI20/00010 to D.E., PI20/00419 to D.E, PI19/01355 to A.M.). I.A. is also funded by Departamento de Salud del Gobierno de Navarra, Spain (ref. G°Na 71/17) D.A. acknowledges funding from The Spanish Association against Cancer (AECC; PROYE16001ESCO), Biomedicine Project Grant from the Department of Health of the Government of Navarre-FEDER funds (BMED 050-2019, 51-2021) and Strategic projects from the Department of Industry, Government of Navarre (AGATA, ref. 0011-1411; LINTERNA, ref. 0011–1411; DESCARTHES, 0011-1411-2019-000058). M.R.-M. is funded by a PhD studentship from the Department of Industry of the Government of Navarra, Spain and by the Grupo Español Multidisciplinar de Melanoma. The University of Colorado School of Medicine Metabolomics Core is supported in part by the University of Colorado Cancer Center award from the National Cancer Institute P30CA046934. Research in the S.A.B. laboratory is supported partially by the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement no. 787041), the Government of Cataluña (SGR grant), the Government of Spain (MINECO), the La Marató/TV3 Foundation, the Foundation Lilliane Bettencourt, the Spanish Association for Cancer Research (AECC) and the Worldwide Cancer Research Foundation (WCRF).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

The epidermal circadian clock integrates and subverts brain signals to guarantee skin homeostasis

  • Mortimer, Thomas
  • Zinna, Valentina M.
  • Atalay, Muge
  • Laudanna, Carmelo
  • Deryagin, Oleg
  • Posas, Guillem
  • Smith, Jacob G.
  • García Lara, Elisa
  • Vaca Dempere, Mireia, 1994-
  • Monteiro de Assis, Leonardo Vinícius
  • Heyde, Isabel
  • Koronowski, Kevin B.
  • Petrus, Paul
  • Greco, Carolina M.
  • Forrow, Stephen
  • Oster, Henrik
  • Sassone-Corsi, Paolo
  • Welz, Patrick-Simon
  • Muñoz Cánoves, Pura, 1962-
  • Aznar Benitah, Salvador
In mammals, the circadian clock network drives daily rhythms of tissue-specific homeostasis. To dissect daily inter-tissue communication, we constructed a mouse minimal clock network comprising only two nodes: the peripheral epidermal clock and the central brain clock. By transcriptomic and functional characterization of this isolated connection, we identified a gatekeeping function of the peripheral tissue clock with respect to systemic inputs. The epidermal clock concurrently integrates and subverts brain signals to ensure timely execution of epidermal daily physiology. Timely cell-cycle termination in the epidermal stem cell compartment depends upon incorporation of clock-driven signals originating from the brain. In contrast, the epidermal clock corrects or outcompetes potentially disruptive feeding-related signals to ensure the optimal timing of DNA replication. Together, we present an approach for cataloging the systemic dependencies of daily temporal organization in a tissue and identify an essential gate-keeping function of peripheral circadian clocks that guarantees tissue homeostasis., We thank the genomics units at the CNAG and CRG for assistance with RNA sequencing, Prof. Gregor Eichele for generously providing us with the Syt10-Cre mice, and Veronica Raker for proofreading the manuscript. The authors acknowledge the following funding sources: SAB - European Research Council under the European Union’s Horizon 2020 (H2020) research and innovation programme (Grant agreement No. 787041), the Government of Cataluña (SGR grant), the Government of Spain (MINECO) and the Foundation Lilliane Bettencourt. The IRB Barcelona is a Severo Ochoa Center of Excellence (MINECO award SEV-2015-0505). CMG - H2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement 749869. KBK - NIH F32 (Fellowship DK121425). PMC - MICINN-RTI2018-096068, ERC-2016-AdG-741966, LaCaixa-HEALTH-HR17-00040, MDA, UPGRADE-H2020-825825, AFM, DPP-Spain, Fundació La MaratóTV3-80/19-202021, MWRF, and María-de-Maeztu Program for Units of Excellence to UPF (MDM-2014-0370) and the Severo- Ochoa Program for Centers of Excellence to CNIC (SEV-2015-0505). PP - Wenner-Gren foundations, The foundation Blanceflor, Tore Nilsons foundation and the Novo Nordisk foundation. PSW - RYC2019-026661-I funded by MCIN/AEI/10.13039/501100011033, "ESF Investing in your future", PID2020-113317RA-I00 funded by MCIN/AEI/ 10.13039/501100011033, and by the BBVA Foundation. TM - H2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No. 754510. VMZ - “la Caixa” INPhINIT Fellowship Grant for Doctoral Studies at Spanish Research Centers of Excellence, “la Caixa'' Foundation, Barcelona (ID 100010434, fellowship LCF/BQ/IN17/11620018). The project has received funding from the H2020 research and innovation program (Marie Skłodowska-Curie grant agreement no. 713673). HO - the German Research Foundation (DFG) -CRC296/TP13.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Impact of Bmal1 rescue and time-restricted feeding on liver and muscle proteomes during the active phase in mice

  • Smith, Jacob G.
  • Molendijk, Jeffrey
  • Blazev, Ronnie
  • Chen, Wan Hsi
  • Zhang, Qing
  • Litwin, Christopher
  • Zinna, Valentina M.
  • Welz, Patrick-Simon
  • Aznar Benitah, Salvador
  • Greco, Carolina M.
  • Sassone-Corsi, Paolo
  • Muñoz Cánoves, Pura, 1962-
  • Parker, Benjamin L.
  • Koronowski, Kevin B.
Molecular clocks and daily feeding cycles support metabolism in peripheral tissues. Although the roles of local clocks and feeding are well defined at the transcriptional level, their impact on governing protein abundance in peripheral tissues is unclear. Here, we determine the relative contributions of local molecular clocks and daily feeding cycles on liver and muscle proteomes during the active phase in mice. LC-MS/MS was performed on liver and gastrocnemius muscle harvested 4 h into the dark phase from WT, Bmal1 KO, and dual liver- and muscle-Bmal1-rescued mice under either ad libitum feeding or time-restricted feeding during the dark phase. Feeding-fasting cycles had only minimal effects on levels of liver proteins and few, if any, on the muscle proteome. In contrast, Bmal1 KO altered the abundance of 674 proteins in liver and 80 proteins in muscle. Local rescue of liver and muscle Bmal1 restored ∼50% of proteins in liver and ∼25% in muscle. These included proteins involved in fatty acid oxidation in liver and carbohydrate metabolism in muscle. For liver, proteins involved in de novo lipogenesis were largely dependent on Bmal1 function in other tissues (i.e., the wider clock system). Proteins regulated by BMAL1 in liver and muscle were enriched for secreted proteins. We found that the abundance of fibroblast growth factor 1, a liver secreted protein, requires BMAL1 and that autocrine fibroblast growth factor 1 signaling modulates mitochondrial respiration in hepatocytes. In liver and muscle, BMAL1 is a more potent regulator of dark phase proteomes than daily feeding cycles, highlighting the need to assess protein levels in addition to mRNA when investigating clock mechanisms. The proteome is more extensively regulated by BMAL1 in liver than in muscle, and many metabolic pathways in peripheral tissues are reliant on the function of the clock system as a whole., The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Work in the B. L. P. laboratory was funded by an NHMRC Emerging Leader Investigator Grant (APP2009642) and a University of Melbourne Driving Research Momentum Grant. C. M. G. was supported by the National Cancer Institute of the National Institutes of Health under award T32CA009054 and by the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement 749869. P. S. W. was supported by grant RYC2019-026661-I funded by MCIN/AEI/10.13039/501100011033 and by "ESF Investing in your future", grant PID2020-113317RA-I00 funded by MCIN/AEI/ 10.13039/501100011033, and by the BBVA Foundation. Research in the S. A. B. lab is supported partially by the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (Grant agreement No. 787041), the Government of Cataluña (SGR grant), the Government of Spain (MINECO), the La Marató/TV3 Foundation, the Foundation Lilliane Bettencourt, the Spanish Association for Cancer Research (AECC), and The Worldwide Cancer Research Foundation (WCRF). The IRB Barcelona is a Severo Ochoa Center of Excellence (MINECO award SEV-2015-0505). P. M. C. acknowledges funding from MICINN-RTI2018-096068, ERC-2016-AdG-741966, LaCaixa-HEALTH-HR17-00040, MDA, UPGRADE-H2020-825825, AFM, DPP-Spain, Fundació La MaratóTV3– 80/19-202021, MWRF, and María-de-Maeztu Program for Units of Excellence to UPF (MDM-2014-0370) and the Severo- Ochoa Program for Centers of Excellence to CNIC (SEV2015-0505). Work in the P.S.-C. laboratory was supported by NIH grants R21DK114652 and R21AG053592, a Challenge Grant from the Novo Nordisk Foundation (NNF202585), KAUST funding (OSR-2019-CRG8-URF/1/4042).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

The central clock suffices to drive the majority of circulatory metabolic rhythms

  • Petrus, Paul
  • Smith, Jacob G.
  • Koronowski, Kevin B.
  • Chen, Siwei
  • Sato, Tomoki
  • Greco, Carolina M.
  • Mortimer, Thomas
  • Welz, Patrick-Simon
  • Zinna, Valentina M.
  • Shimaji, Kohei
  • Cervantes, Marlene
  • Punzo, Daniela
  • Baldi, Pierre
  • Muñoz Cánoves, Pura, 1962-
  • Sassone-Corsi, Paolo
  • Aznar Benitah, Salvador
Life on Earth anticipates recurring 24-hour environmental cycles via genetically encoded molecular clocks active in all mammalian organs. Communication between these clocks controls circadian homeostasis. Intertissue communication is mediated, in part, by temporal coordination of metabolism. Here, we characterize the extent to which clocks in different organs control systemic metabolic rhythms, an area that remains largely unexplored. We analyzed the metabolome of serum from mice with tissue-specific expression of the clock gene Bmal1. Having functional hepatic and muscle clocks can only drive a minority (13%) of systemic metabolic rhythms. Conversely, limiting Bmal1 expression to the central pacemaker in the brain restores rhythms to 57% of circulatory metabolites. Rhythmic feeding imposed on clockless mice resulted in a similar rescue, indicating that the central clock mainly regulates metabolic rhythms via behavior. These findings explicate the circadian communication between tissues and highlight the importance of the central clock in governing those signals., P.P. was funded by the Wenner-Gren Foundation; the Foundation Blanceflor Boncompagni Ludovisi, née Bildt; and the Tore Nilsson Foundation for Medical Science. Funding for P.S.-C. was provided by the National Institutes of Health (NIH) (AG053592 and DK114652), a Novo Nordisk Foundation Challenge Grant, and Institut National de la Sante et la Recherche Medicale (U1233 INSERM, France). Research in the S.A.B. laboratory is supported partially by the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement no. 787041), the Government of Cataluña (SGR grant), the Government of Spain (MINECO), the La Marató/TV3 Foundation, the Foundation Lilliane Bettencourt, the Spanish Association for Cancer Research (AECC), and the Worldwide Cancer Research Foundation (WCRF). The IRB Barcelona is a Severo Ochoa Center of Excellence (MINECO award SEV-2015-0505). P.M.C. acknowledges funding from MICINN-RTI2018-096068, ERC-2016-AdG-741966, LaCaixa-HEALTH-HR17-00040, MDA, UPGRADE-H2020-825825, AFM, DPP-Spain, Fundació La Marató TV3-80/19-202021, MWRF, María-de-Maeztu Program for Units of Excellence to UPF (MDM-2014-0370), and the Severo- Ochoa Program for Centers of Excellence to CNIC (SEV-2015-0505). T.S. was supported by a Japan Society for the Promotion of Science (JSPS) fellowship. C.M.G. was funded by European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement no. 749869. T.M. received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement no. 754510. P.-S.W. is supported by grant RYC2019-026661-I funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future.” We acknowledge predoctoral fellowships to M.C. from the NIH (GM117942), the American Heart Association (17PRE33410952), and the UCI School of Medicine Behrens Research Excellence Award. The work of S.C. and P.B. was, in part, supported by NIH grant NIH GM123558.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Liver and muscle circadian clocks cooperate to support glucose tolerance in mice

  • Smith, Jacob G.
  • Kumar, Arun
  • Deryagin, Oleg
  • Vaca Dempere, Mireia, 1994-
  • Sica, Valentina
  • Welz, Patrick-Simon
  • Muñoz Cánoves, Pura, 1962-
  • Sassone-Corsi, Paolo
Physiology is regulated by interconnected cell and tissue circadian clocks. Disruption of the rhythms generated by the concerted activity of these clocks is associated with metabolic disease. Here we tested the interactions between clocks in two critical components of organismal metabolism, liver and skeletal muscle, by rescuing clock function either in each organ separately or in both organs simultaneously in otherwise clock-less mice. Experiments showed that individual clocks are partially sufficient for tissue glucose metabolism, yet the connections between both tissue clocks coupled to daily feeding rhythms support systemic glucose tolerance. This synergy relies in part on local transcriptional control of the glucose machinery, feeding-responsive signals such as insulin, and metabolic cycles that connect the muscle and liver. We posit that spatiotemporal mechanisms of muscle and liver play an essential role in the maintenance of systemic glucose homeostasis and that disrupting this diurnal coordination can contribute to metabolic disease., This paper is dedicated to Paolo Sassone-Corsi, a hugely inspiring scientist and mentor who remains an important influence on our work. We also thank P.S.C. Lab animal technician S. Sato and laboratory manager W. Orquiz for their valued contributions, as well as Aintzane Rueda and Alfonso Saera-Vila at Sequentia Biotech (Barcelona) for their work on RNA sequencing read alignment and differential gene expression analysis. J.G.S. was supported by Zymo-CEM Postdoctoral Fellowship (Zymo Research) awarded at the University of California, Irvine. K.B.K. was supported by NIH, NIDDK F32 Fellowship – DK121425. T.S. was supported by a Japan Society for the Promotion of Science (JSPS) fellowship. C.M.G. was supported by the National Cancer Institute of the National Institutes of Health under award T32CA009054 and by the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement 749869. P.P. was funded by The Wenner-Gren Foundations, the Foundation Blanceflor Boncompagni Ludovisi, née Bildt and Tore Nilsson Foundation for Medical Science. V.S. was supported by the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement 895390. A.V. was supported by the Hitachi-Nomura postdoctoral fellowship awarded through the Department of Biological Chemistry at the University of California, Irvine. The work of S.C., M.S., and P.B. was in part supported by NIH grant GM123558. C.J. was supported by the AASLD Foundation Pinnacle Research Award in Liver Disease, the Edward Mallinckrodt, Jr. Foundation Award, and NIH/NIAAA R01 AA029124. P.-S.W. is supported by grant RYC2019026661-I funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future.” Financial support for the S.M. laboratory is provided through the NIH/NCI (grants R01CA244519, R01CA259370, and K22CA212045). Research in the S.A.B. lab is supported partially by the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement 787041), the Government of Cataluña (SGR grant), the Government of Spain (MINECO), the La Marató/TV3 Foundation, the Foundation Lilliane Bettencourt, the Spanish Association for Cancer Research (AECC), and the Worldwide Cancer Research Foundation (WCRF). The IRB Barcelona is a Severo Ochoa Center of Excellence (MINECO award SEV-2015-0505). P.M.-C. acknowledges funding from MICINN-RTI2018-096068, ERC-2016-AdG-741966, LaCaixa-HEALTH-HR17-00040, MDA, UPGRADE-H2020-825825, AFM, DPP-Spain, Fundació La MaratóTV3- 80/19-202021, MWRF, and María-de-Maeztu Program for Units of Excellence to UPF (MDM-2014-0370), and the Severo-Ochoa Program for Centers of Excellence to CNIC (SEV2015-0505). Work in the P.S.-C. laboratory is supported by NIH grants R21DK114652 and R21AG053592, a Challenge Grant from the Novo Nordisk Foundation (NNF202585), KAUST funding (OSR-2019-CRG8-URF/1/4042), and via access to the Genomics High Throughput Facility Shared Resource of the Cancer Center Support Grant (CA-62203) and the UCI and NIH-shared instrumentation grants 1S10RR025496-01, 1S10OD010794-01, and 1S10OD021718-01.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Brain-muscle communication prevents muscle aging by maintaining daily physiology

  • Kumar, Arun
  • Vaca Dempere, Mireia, 1994-
  • Mortimer, Thomas
  • Deryagin, Oleg
  • Smith, Jacob G.
  • Petrus, Paul
  • Koronowski, Kevin B.
  • Greco, Carolina M.
  • Segalés Dalmau, Jessica
  • Andrés, Eva
  • Lukesova, Vera
  • Zinna, Valentina M.
  • Welz, Patrick-Simon
  • Serrano Sánchez, Antonio L.
  • Perdiguero, Eusebio, 1968-
  • Sassone-Corsi, Paolo
  • Aznar Benitah, Salvador
  • Muñoz Cánoves, Pura, 1962-
A molecular clock network is crucial for daily physiology and maintaining organismal health. We examined the interactions and importance of intratissue clock networks in muscle tissue maintenance. In arrhythmic mice showing premature aging, we created a basic clock module involving a central and a peripheral (muscle) clock. Reconstituting the brain-muscle clock network is sufficient to preserve fundamental daily homeostatic functions and prevent premature muscle aging. However, achieving whole muscle physiology requires contributions from other peripheral clocks. Mechanistically, the muscle peripheral clock acts as a gatekeeper, selectively suppressing detrimental signals from the central clock while integrating important muscle homeostatic functions. Our research reveals the interplay between the central and peripheral clocks in daily muscle function and underscores the impact of eating patterns on these interactions., The authors acknowledge funding from MICINN-Spain (RTI2018-096068 to P.M.-C. and E.P.), ERC-2016-AdG-741966 to P.M.-C., María-de-Maeztu Program for Units of Excellence to UPF (MDM-2014-0370), and Altos Labs Inc. Research in the S.A.B. laboratory is supported by ERC-787041, the Foundation Lilliane Bettencourt, the Spanish Association for Cancer Research (AECC), and the Worldwide Cancer Research Foundation (WCRF). The IRB Barcelona is a Severo Ochoa Center of Excellence (SEV-2015-0505). K.B.K. acknowledges funding from NIH F32 Fellowship DK121425. P.P. was funded by The Wenner-Gren Foundations and the Foundation Blanceflor Boncompagni Ludovisi, née Bildt. C.M.G. acknowledges funding from European Union’s Horizon 2020 Research and Innovation Programme under the Marie Sklodowska-Curie grant agreement 749869. P.P. was funded by the Wenner-Gren Foundations and the Foundation Blanceflor Boncompagni Ludovisi, née Bildt. V.M.Z. received financial support through the “la Caixa” INPhINIT fellowship grant for doctoral studies at Spanish Research Centers of Excellence, “la Caixa” Foundation, Barcelona (ID 100010434) with fellowship code (LCF/BQ/IN17/11620018). P.-S.W. is supported by grant RYC2019-026661-I funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future.”
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Targeting lymphoid-derived IL-17 signaling to delay skin aging

  • Solá, Paloma
  • Mereu, Elisabetta
  • Bonjoch, Júlia
  • Casado-Peláez, Marta
  • Prats, Neus
  • Aguilera, Mònica
  • Reina García, Óscar, 1976-
  • Blanco, Enrique
  • Esteller, Manel
  • Di Croce, Luciano
  • Heyn, Holger
  • Solanas, Guiomar
  • Aznar Benitah, Salvador
Skin aging is characterized by structural and functional changes that contribute to age-associated frailty. This probably depends on synergy between alterations in the local niche and stem cell-intrinsic changes, underscored by proinflammatory microenvironments that drive pleotropic changes. The nature of these age-associated inflammatory cues, or how they affect tissue aging, is unknown. Based on single-cell RNA sequencing of the dermal compartment of mouse skin, we show a skew towards an IL-17-expressing phenotype of T helper cells, γδ T cells and innate lymphoid cells in aged skin. Importantly, in vivo blockade of IL-17 signaling during aging reduces the proinflammatory state of the skin, delaying the appearance of age-related traits. Mechanistically, aberrant IL-17 signals through NF-κB in epidermal cells to impair homeostatic functions while promoting an inflammatory state. Our results indicate that aged skin shows signs of chronic inflammation and that increased IL-17 signaling could be targeted to prevent age-associated skin ailments., Research in the S.A.B. laboratory is supported partially by the European Research Council under the European Union’s Horizon 2020 research and innovation program (grant agreement no. 787041), the Government of Cataluña (SGR grant), the Government of Spain (MINECO) and Foundation Lilliane Bettencourt. This work was partially supported by a Leonardo grant (BBVA Foundation) awarded to G.S. P.S. was awarded a Spanish Ministry of Economy and Development fellowship (MINECO, no. BES-2017-081279). J.B. was awarded a Spanish Ministry of Science and Innovation fellowship (MCI, no. PRE-2021-097118). M.E. and E.M. were supported by Ministerio de Ciencia e Innovación (MCI), Agencia Estatal de Investigación (AEI) and the European Development Regional Fund, ‘A way to make Europe’ ERDF (no. RTI2018-094049-B-I00). H.H. has received funding from Ministerio de Ciencia, Innovación y Universidades (no. SAF2017-89109-P; AEI/FEDER, UE). IRB Barcelona is a Severo Ochoa Center of Excellence (MINECO award no. SEV-2015-0505). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. We thank the histopathology, advanced digital microscopy and genomics facilities of IRB Barcelona and the genomics unit at CRG. We thank C. Niessen and E. Wachsmuth for useful tips on TEWL usage. We thank V. Raker for manuscript editing.
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

Loss of G9a preserves mutation patterns but increases chromatin accessibility, genomic instability and aggressiveness in skin tumours

  • Avgustinova, Alexandra
  • Symeonidi, Aikaterini
  • Castellanos, Andrés
  • Urdiroz Urricelqui, Uxue
  • Solé Boldo, Llorenç
  • Martín, Mercè
  • Pérez Rodríguez, Ivan
  • Prats, Neus
  • Lehner, Ben, 1978-
  • Supek, Fran
  • Aznar Benitah, Salvador
Mutations in, and the altered expression of, epigenetic modifiers are pervasive in human tumours, making epigenetic factors attractive antitumour targets. The open-versus-closed chromatin state within the cells-of-origin of cancer correlates with the uneven distribution of mutations. However, the long-term effect of targeting epigenetic modifiers on mutability in patients with cancer is unclear. Here, we increased chromatin accessibility by deleting the histone H3 lysine 9 (H3K9) methyltransferase G9a in murine epidermis and show that this does not alter the single nucleotide variant burden or global genomic distribution in chemical mutagen-induced squamous tumours. G9a-depleted tumours develop after a prolonged latency compared with their wild-type counterparts, but are more aggressive and have an expanded cancer progenitor pool, pronounced genomic instability and frequent loss-of-function p53 mutations. Thus, we call for caution when assessing long-term therapeutic benefits of chromatin modifier inhibitors, which may promote more aggressive disease.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Metabolic rewiring induced by ranolazine improves melanoma responses to targeted therapy and immunotherapy

  • Redondo-Muñoz, Marta
  • Rodríguez-Baena, Francisco Javier
  • Matheu, Ander
  • Wellbrock, Claudia
  • Aznar Benitah, Salvador
  • Sánchez-Laorden, Berta
  • Arozarena, Imanol
Redondo-Muñoz, M., Rodriguez-Baena, F.J., Aldaz, P. et al., Resistance of melanoma to targeted therapy and immunotherapy is linked to metabolic rewiring. Here, we show that increased fatty acid oxidation (FAO) during prolonged BRAF inhibitor (BRAFi) treatment contributes to acquired therapy resistance in mice. Targeting FAO using the US Food and Drug Administration-approved and European Medicines Agency-approved anti-anginal drug ranolazine (RANO) delays tumour recurrence with acquired BRAFi resistance. Single-cell RNA-sequencing analysis reveals that RANO diminishes the abundance of the therapy-resistant NGFRhi neural crest stem cell subpopulation. Moreover, by rewiring the methionine salvage pathway, RANO enhances melanoma immunogenicity through increased antigen presentation and interferon signalling. Combination of RANO with anti-PD-L1 antibodies strongly improves survival by increasing antitumour immune responses. Altogether, we show that RANO increases the efficacy of targeted melanoma therapy through its effects on FAO and the methionine salvage pathway. Importantly, our study suggests that RANO could sensitize BRAFi-resistant tumours to immunotherapy. Since RANO has very mild side-effects, it might constitute a therapeutic option to improve the two main strategies currently used to treat metastatic melanoma., I.A., P.A., D.E. and A.M. acknowledge funding from the Ministry of Economy and Competitiveness (Institute of Health Carlos III; refs. PI19/00645 to I.A., PI16-01911 to I.A., CPII20/00011 to I.A., CD21/00137 to P.A., PI20/00010 to D.E., PI20/00419 to D.E, PI19/01355 to A.M.). I.A. is also funded by Departamento de Salud del Gobierno de Navarra, Spain (ref. G°Na 71/17) D.A. acknowledges funding from The Spanish Association against Cancer (AECC; PROYE16001ESCO), Biomedicine Project Grant from the Department of Health of the Government of Navarre-FEDER funds (BMED 050-2019, 51-2021) and Strategic projects from the Department of Industry, Government of Navarre (AGATA, ref. 0011-1411; LINTERNA, ref. 0011–1411; DESCARTHES, 0011-1411-2019-000058). M.R.-M. is funded by a PhD studentship from the Department of Industry of the Government of Navarra, Spain and by the Grupo Español Multidisciplinar de Melanoma. The University of Colorado School of Medicine Metabolomics Core is supported in part by the University of Colorado Cancer Center award from the National Cancer Institute P30CA046934. Research in the S.A.B. laboratory is supported partially by the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement no. 787041), the Government of Cataluña (SGR grant), the Government of Spain (MINECO), the La Marató/TV3 Foundation, the Foundation Lilliane Bettencourt, the Spanish Association for Cancer Research (AECC) and the Worldwide Cancer Research Foundation (WCRF). Work in the laboratory of B.S.-L. is supported by: PID2019-106852-RBI00 funded by MCIN/AEI/10.13039/501100011033, the Melanoma Research Alliance (https://doi.org/10.48050/pc.gr.91574) and the FERO Foundation., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Loss of G9a preserves mutation patterns but increases chromatin accessibility, genomic instability and aggressiveness in skin tumours

  • Avgustinova, Alexandra
  • Symeonidi, Aikaterini
  • Castellanos, Andrés
  • Urdiroz Urricelqui, Uxue
  • Solé Boldo, Llorenç
  • Martín, Mercè
  • Pérez Rodríguez, Ivan
  • Prats, Neus
  • Lehner, Ben, 1978-
  • Supek, Fran
  • Aznar Benitah, Salvador
Mutations in, and the altered expression of, epigenetic modifiers are pervasive in human tumours, making epigenetic factors attractive antitumour targets. The open-versus-closed chromatin state within the cells-of-origin of cancer correlates with the uneven distribution of mutations. However, the long-term effect of targeting epigenetic modifiers on mutability in patients with cancer is unclear. Here, we increased chromatin accessibility by deleting the histone H3 lysine 9 (H3K9) methyltransferase G9a in murine epidermis and show that this does not alter the single nucleotide variant burden or global genomic distribution in chemical mutagen-induced squamous tumours. G9a-depleted tumours develop after a prolonged latency compared with their wild-type counterparts, but are more aggressive and have an expanded cancer progenitor pool, pronounced genomic instability and frequent loss-of-function p53 mutations. Thus, we call for caution when assessing long-term therapeutic benefits of chromatin modifier inhibitors, which may promote more aggressive disease.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Impact of Bmal1 rescue and time-restricted feeding on liver and muscle proteomes during the active phase in mice

  • Smith, Jacob G.
  • Molendijk, Jeffrey
  • Blazev, Ronnie
  • Chen, Wan Hsi
  • Zhang, Qing
  • Litwin, Christopher
  • Zinna, Valentina M.
  • Welz, Patrick-Simon
  • Aznar Benitah, Salvador
  • Greco, Carolina M.
  • Sassone-Corsi, Paolo
  • Muñoz Cánoves, Pura, 1962-
  • Parker, Benjamin L.
  • Koronowski, Kevin B.
Molecular clocks and daily feeding cycles support metabolism in peripheral tissues. Although the roles of local clocks and feeding are well defined at the transcriptional level, their impact on governing protein abundance in peripheral tissues is unclear. Here, we determine the relative contributions of local molecular clocks and daily feeding cycles on liver and muscle proteomes during the active phase in mice. LC-MS/MS was performed on liver and gastrocnemius muscle harvested 4 h into the dark phase from WT, Bmal1 KO, and dual liver- and muscle-Bmal1-rescued mice under either ad libitum feeding or time-restricted feeding during the dark phase. Feeding-fasting cycles had only minimal effects on levels of liver proteins and few, if any, on the muscle proteome. In contrast, Bmal1 KO altered the abundance of 674 proteins in liver and 80 proteins in muscle. Local rescue of liver and muscle Bmal1 restored ∼50% of proteins in liver and ∼25% in muscle. These included proteins involved in fatty acid oxidation in liver and carbohydrate metabolism in muscle. For liver, proteins involved in de novo lipogenesis were largely dependent on Bmal1 function in other tissues (i.e., the wider clock system). Proteins regulated by BMAL1 in liver and muscle were enriched for secreted proteins. We found that the abundance of fibroblast growth factor 1, a liver secreted protein, requires BMAL1 and that autocrine fibroblast growth factor 1 signaling modulates mitochondrial respiration in hepatocytes. In liver and muscle, BMAL1 is a more potent regulator of dark phase proteomes than daily feeding cycles, highlighting the need to assess protein levels in addition to mRNA when investigating clock mechanisms. The proteome is more extensively regulated by BMAL1 in liver than in muscle, and many metabolic pathways in peripheral tissues are reliant on the function of the clock system as a whole., The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Work in the B. L. P. laboratory was funded by an NHMRC Emerging Leader Investigator Grant (APP2009642) and a University of Melbourne Driving Research Momentum Grant. C. M. G. was supported by the National Cancer Institute of the National Institutes of Health under award T32CA009054 and by the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement 749869. P. S. W. was supported by grant RYC2019-026661-I funded by MCIN/AEI/10.13039/501100011033 and by "ESF Investing in your future", grant PID2020-113317RA-I00 funded by MCIN/AEI/ 10.13039/501100011033, and by the BBVA Foundation. Research in the S. A. B. lab is supported partially by the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (Grant agreement No. 787041), the Government of Cataluña (SGR grant), the Government of Spain (MINECO), the La Marató/TV3 Foundation, the Foundation Lilliane Bettencourt, the Spanish Association for Cancer Research (AECC), and The Worldwide Cancer Research Foundation (WCRF). The IRB Barcelona is a Severo Ochoa Center of Excellence (MINECO award SEV-2015-0505). P. M. C. acknowledges funding from MICINN-RTI2018-096068, ERC-2016-AdG-741966, LaCaixa-HEALTH-HR17-00040, MDA, UPGRADE-H2020-825825, AFM, DPP-Spain, Fundació La MaratóTV3– 80/19-202021, MWRF, and María-de-Maeztu Program for Units of Excellence to UPF (MDM-2014-0370) and the Severo- Ochoa Program for Centers of Excellence to CNIC (SEV2015-0505). Work in the P.S.-C. laboratory was supported by NIH grants R21DK114652 and R21AG053592, a Challenge Grant from the Novo Nordisk Foundation (NNF202585), KAUST funding (OSR-2019-CRG8-URF/1/4042).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Brain-muscle communication prevents muscle aging by maintaining daily physiology

  • Kumar, Arun
  • Vaca Dempere, Mireia, 1994-
  • Mortimer, Thomas
  • Deryagin, Oleg
  • Smith, Jacob G.
  • Petrus, Paul
  • Koronowski, Kevin B.
  • Greco, Carolina M.
  • Segalés Dalmau, Jessica
  • Andrés, Eva
  • Lukesova, Vera
  • Zinna, Valentina M.
  • Welz, Patrick-Simon
  • Serrano Sánchez, Antonio L.
  • Perdiguero, Eusebio, 1968-
  • Sassone-Corsi, Paolo
  • Aznar Benitah, Salvador
  • Muñoz Cánoves, Pura, 1962-
A molecular clock network is crucial for daily physiology and maintaining organismal health. We examined the interactions and importance of intratissue clock networks in muscle tissue maintenance. In arrhythmic mice showing premature aging, we created a basic clock module involving a central and a peripheral (muscle) clock. Reconstituting the brain-muscle clock network is sufficient to preserve fundamental daily homeostatic functions and prevent premature muscle aging. However, achieving whole muscle physiology requires contributions from other peripheral clocks. Mechanistically, the muscle peripheral clock acts as a gatekeeper, selectively suppressing detrimental signals from the central clock while integrating important muscle homeostatic functions. Our research reveals the interplay between the central and peripheral clocks in daily muscle function and underscores the impact of eating patterns on these interactions., The authors acknowledge funding from MICINN-Spain (RTI2018-096068 to P.M.-C. and E.P.), ERC-2016-AdG-741966 to P.M.-C., María-de-Maeztu Program for Units of Excellence to UPF (MDM-2014-0370), and Altos Labs Inc. Research in the S.A.B. laboratory is supported by ERC-787041, the Foundation Lilliane Bettencourt, the Spanish Association for Cancer Research (AECC), and the Worldwide Cancer Research Foundation (WCRF). The IRB Barcelona is a Severo Ochoa Center of Excellence (SEV-2015-0505). K.B.K. acknowledges funding from NIH F32 Fellowship DK121425. P.P. was funded by The Wenner-Gren Foundations and the Foundation Blanceflor Boncompagni Ludovisi, née Bildt. C.M.G. acknowledges funding from European Union’s Horizon 2020 Research and Innovation Programme under the Marie Sklodowska-Curie grant agreement 749869. P.P. was funded by the Wenner-Gren Foundations and the Foundation Blanceflor Boncompagni Ludovisi, née Bildt. V.M.Z. received financial support through the “la Caixa” INPhINIT fellowship grant for doctoral studies at Spanish Research Centers of Excellence, “la Caixa” Foundation, Barcelona (ID 100010434) with fellowship code (LCF/BQ/IN17/11620018). P.-S.W. is supported by grant RYC2019-026661-I funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future.”
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The epidermal circadian clock integrates and subverts brain signals to guarantee skin homeostasis

  • Mortimer, Thomas
  • Zinna, Valentina M.
  • Atalay, Muge
  • Laudanna, Carmelo
  • Deryagin, Oleg
  • Posas, Guillem
  • Smith, Jacob G.
  • García Lara, Elisa
  • Vaca Dempere, Mireia, 1994-
  • Monteiro de Assis, Leonardo Vinícius
  • Heyde, Isabel
  • Koronowski, Kevin B.
  • Petrus, Paul
  • Greco, Carolina M.
  • Forrow, Stephen
  • Oster, Henrik
  • Sassone-Corsi, Paolo
  • Welz, Patrick-Simon
  • Muñoz Cánoves, Pura, 1962-
  • Aznar Benitah, Salvador
In mammals, the circadian clock network drives daily rhythms of tissue-specific homeostasis. To dissect daily inter-tissue communication, we constructed a mouse minimal clock network comprising only two nodes: the peripheral epidermal clock and the central brain clock. By transcriptomic and functional characterization of this isolated connection, we identified a gatekeeping function of the peripheral tissue clock with respect to systemic inputs. The epidermal clock concurrently integrates and subverts brain signals to ensure timely execution of epidermal daily physiology. Timely cell-cycle termination in the epidermal stem cell compartment depends upon incorporation of clock-driven signals originating from the brain. In contrast, the epidermal clock corrects or outcompetes potentially disruptive feeding-related signals to ensure the optimal timing of DNA replication. Together, we present an approach for cataloging the systemic dependencies of daily temporal organization in a tissue and identify an essential gate-keeping function of peripheral circadian clocks that guarantees tissue homeostasis., We thank the genomics units at the CNAG and CRG for assistance with RNA sequencing, Prof. Gregor Eichele for generously providing us with the Syt10-Cre mice, and Veronica Raker for proofreading the manuscript. The authors acknowledge the following funding sources: SAB - European Research Council under the European Union’s Horizon 2020 (H2020) research and innovation programme (Grant agreement No. 787041), the Government of Cataluña (SGR grant), the Government of Spain (MINECO) and the Foundation Lilliane Bettencourt. The IRB Barcelona is a Severo Ochoa Center of Excellence (MINECO award SEV-2015-0505). CMG - H2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement 749869. KBK - NIH F32 (Fellowship DK121425). PMC - MICINN-RTI2018-096068, ERC-2016-AdG-741966, LaCaixa-HEALTH-HR17-00040, MDA, UPGRADE-H2020-825825, AFM, DPP-Spain, Fundació La MaratóTV3-80/19-202021, MWRF, and María-de-Maeztu Program for Units of Excellence to UPF (MDM-2014-0370) and the Severo- Ochoa Program for Centers of Excellence to CNIC (SEV-2015-0505). PP - Wenner-Gren foundations, The foundation Blanceflor, Tore Nilsons foundation and the Novo Nordisk foundation. PSW - RYC2019-026661-I funded by MCIN/AEI/10.13039/501100011033, "ESF Investing in your future", PID2020-113317RA-I00 funded by MCIN/AEI/ 10.13039/501100011033, and by the BBVA Foundation. TM - H2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No. 754510. VMZ - “la Caixa” INPhINIT Fellowship Grant for Doctoral Studies at Spanish Research Centers of Excellence, “la Caixa'' Foundation, Barcelona (ID 100010434, fellowship LCF/BQ/IN17/11620018). The project has received funding from the H2020 research and innovation program (Marie Skłodowska-Curie grant agreement no. 713673). HO - the German Research Foundation (DFG) -CRC296/TP13.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Targeting lymphoid-derived IL-17 signaling to delay skin aging

  • Solá, Paloma
  • Mereu, Elisabetta
  • Bonjoch, Júlia
  • Casado-Peláez, Marta
  • Prats, Neus
  • Aguilera, Mònica
  • Reina García, Óscar, 1976-
  • Blanco, Enrique
  • Esteller, Manel
  • Di Croce, Luciano
  • Heyn, Holger
  • Solanas, Guiomar
  • Aznar Benitah, Salvador
Skin aging is characterized by structural and functional changes that contribute to age-associated frailty. This probably depends on synergy between alterations in the local niche and stem cell-intrinsic changes, underscored by proinflammatory microenvironments that drive pleotropic changes. The nature of these age-associated inflammatory cues, or how they affect tissue aging, is unknown. Based on single-cell RNA sequencing of the dermal compartment of mouse skin, we show a skew towards an IL-17-expressing phenotype of T helper cells, γδ T cells and innate lymphoid cells in aged skin. Importantly, in vivo blockade of IL-17 signaling during aging reduces the proinflammatory state of the skin, delaying the appearance of age-related traits. Mechanistically, aberrant IL-17 signals through NF-κB in epidermal cells to impair homeostatic functions while promoting an inflammatory state. Our results indicate that aged skin shows signs of chronic inflammation and that increased IL-17 signaling could be targeted to prevent age-associated skin ailments., Research in the S.A.B. laboratory is supported partially by the European Research Council under the European Union’s Horizon 2020 research and innovation program (grant agreement no. 787041), the Government of Cataluña (SGR grant), the Government of Spain (MINECO) and Foundation Lilliane Bettencourt. This work was partially supported by a Leonardo grant (BBVA Foundation) awarded to G.S. P.S. was awarded a Spanish Ministry of Economy and Development fellowship (MINECO, no. BES-2017-081279). J.B. was awarded a Spanish Ministry of Science and Innovation fellowship (MCI, no. PRE-2021-097118). M.E. and E.M. were supported by Ministerio de Ciencia e Innovación (MCI), Agencia Estatal de Investigación (AEI) and the European Development Regional Fund, ‘A way to make Europe’ ERDF (no. RTI2018-094049-B-I00). H.H. has received funding from Ministerio de Ciencia, Innovación y Universidades (no. SAF2017-89109-P; AEI/FEDER, UE). IRB Barcelona is a Severo Ochoa Center of Excellence (MINECO award no. SEV-2015-0505). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. We thank the histopathology, advanced digital microscopy and genomics facilities of IRB Barcelona and the genomics unit at CRG. We thank C. Niessen and E. Wachsmuth for useful tips on TEWL usage. We thank V. Raker for manuscript editing.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The central clock suffices to drive the majority of circulatory metabolic rhythms

  • Petrus, Paul
  • Smith, Jacob G.
  • Koronowski, Kevin B.
  • Chen, Siwei
  • Sato, Tomoki
  • Greco, Carolina M.
  • Mortimer, Thomas
  • Welz, Patrick-Simon
  • Zinna, Valentina M.
  • Shimaji, Kohei
  • Cervantes, Marlene
  • Punzo, Daniela
  • Baldi, Pierre
  • Muñoz Cánoves, Pura, 1962-
  • Sassone-Corsi, Paolo
  • Aznar Benitah, Salvador
Life on Earth anticipates recurring 24-hour environmental cycles via genetically encoded molecular clocks active in all mammalian organs. Communication between these clocks controls circadian homeostasis. Intertissue communication is mediated, in part, by temporal coordination of metabolism. Here, we characterize the extent to which clocks in different organs control systemic metabolic rhythms, an area that remains largely unexplored. We analyzed the metabolome of serum from mice with tissue-specific expression of the clock gene Bmal1. Having functional hepatic and muscle clocks can only drive a minority (13%) of systemic metabolic rhythms. Conversely, limiting Bmal1 expression to the central pacemaker in the brain restores rhythms to 57% of circulatory metabolites. Rhythmic feeding imposed on clockless mice resulted in a similar rescue, indicating that the central clock mainly regulates metabolic rhythms via behavior. These findings explicate the circadian communication between tissues and highlight the importance of the central clock in governing those signals., P.P. was funded by the Wenner-Gren Foundation; the Foundation Blanceflor Boncompagni Ludovisi, née Bildt; and the Tore Nilsson Foundation for Medical Science. Funding for P.S.-C. was provided by the National Institutes of Health (NIH) (AG053592 and DK114652), a Novo Nordisk Foundation Challenge Grant, and Institut National de la Sante et la Recherche Medicale (U1233 INSERM, France). Research in the S.A.B. laboratory is supported partially by the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement no. 787041), the Government of Cataluña (SGR grant), the Government of Spain (MINECO), the La Marató/TV3 Foundation, the Foundation Lilliane Bettencourt, the Spanish Association for Cancer Research (AECC), and the Worldwide Cancer Research Foundation (WCRF). The IRB Barcelona is a Severo Ochoa Center of Excellence (MINECO award SEV-2015-0505). P.M.C. acknowledges funding from MICINN-RTI2018-096068, ERC-2016-AdG-741966, LaCaixa-HEALTH-HR17-00040, MDA, UPGRADE-H2020-825825, AFM, DPP-Spain, Fundació La Marató TV3-80/19-202021, MWRF, María-de-Maeztu Program for Units of Excellence to UPF (MDM-2014-0370), and the Severo- Ochoa Program for Centers of Excellence to CNIC (SEV-2015-0505). T.S. was supported by a Japan Society for the Promotion of Science (JSPS) fellowship. C.M.G. was funded by European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement no. 749869. T.M. received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement no. 754510. P.-S.W. is supported by grant RYC2019-026661-I funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future.” We acknowledge predoctoral fellowships to M.C. from the NIH (GM117942), the American Heart Association (17PRE33410952), and the UCI School of Medicine Behrens Research Excellence Award. The work of S.C. and P.B. was, in part, supported by NIH grant NIH GM123558.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Liver and muscle circadian clocks cooperate to support glucose tolerance in mice

  • Smith, Jacob G.
  • Kumar, Arun
  • Deryagin, Oleg
  • Vaca Dempere, Mireia, 1994-
  • Sica, Valentina
  • Welz, Patrick-Simon
  • Muñoz Cánoves, Pura, 1962-
  • Sassone-Corsi, Paolo
Physiology is regulated by interconnected cell and tissue circadian clocks. Disruption of the rhythms generated by the concerted activity of these clocks is associated with metabolic disease. Here we tested the interactions between clocks in two critical components of organismal metabolism, liver and skeletal muscle, by rescuing clock function either in each organ separately or in both organs simultaneously in otherwise clock-less mice. Experiments showed that individual clocks are partially sufficient for tissue glucose metabolism, yet the connections between both tissue clocks coupled to daily feeding rhythms support systemic glucose tolerance. This synergy relies in part on local transcriptional control of the glucose machinery, feeding-responsive signals such as insulin, and metabolic cycles that connect the muscle and liver. We posit that spatiotemporal mechanisms of muscle and liver play an essential role in the maintenance of systemic glucose homeostasis and that disrupting this diurnal coordination can contribute to metabolic disease., This paper is dedicated to Paolo Sassone-Corsi, a hugely inspiring scientist and mentor who remains an important influence on our work. We also thank P.S.C. Lab animal technician S. Sato and laboratory manager W. Orquiz for their valued contributions, as well as Aintzane Rueda and Alfonso Saera-Vila at Sequentia Biotech (Barcelona) for their work on RNA sequencing read alignment and differential gene expression analysis. J.G.S. was supported by Zymo-CEM Postdoctoral Fellowship (Zymo Research) awarded at the University of California, Irvine. K.B.K. was supported by NIH, NIDDK F32 Fellowship – DK121425. T.S. was supported by a Japan Society for the Promotion of Science (JSPS) fellowship. C.M.G. was supported by the National Cancer Institute of the National Institutes of Health under award T32CA009054 and by the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement 749869. P.P. was funded by The Wenner-Gren Foundations, the Foundation Blanceflor Boncompagni Ludovisi, née Bildt and Tore Nilsson Foundation for Medical Science. V.S. was supported by the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement 895390. A.V. was supported by the Hitachi-Nomura postdoctoral fellowship awarded through the Department of Biological Chemistry at the University of California, Irvine. The work of S.C., M.S., and P.B. was in part supported by NIH grant GM123558. C.J. was supported by the AASLD Foundation Pinnacle Research Award in Liver Disease, the Edward Mallinckrodt, Jr. Foundation Award, and NIH/NIAAA R01 AA029124. P.-S.W. is supported by grant RYC2019026661-I funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future.” Financial support for the S.M. laboratory is provided through the NIH/NCI (grants R01CA244519, R01CA259370, and K22CA212045). Research in the S.A.B. lab is supported partially by the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement 787041), the Government of Cataluña (SGR grant), the Government of Spain (MINECO), the La Marató/TV3 Foundation, the Foundation Lilliane Bettencourt, the Spanish Association for Cancer Research (AECC), and the Worldwide Cancer Research Foundation (WCRF). The IRB Barcelona is a Severo Ochoa Center of Excellence (MINECO award SEV-2015-0505). P.M.-C. acknowledges funding from MICINN-RTI2018-096068, ERC-2016-AdG-741966, LaCaixa-HEALTH-HR17-00040, MDA, UPGRADE-H2020-825825, AFM, DPP-Spain, Fundació La MaratóTV3- 80/19-202021, MWRF, and María-de-Maeztu Program for Units of Excellence to UPF (MDM-2014-0370), and the Severo-Ochoa Program for Centers of Excellence to CNIC (SEV2015-0505). Work in the P.S.-C. laboratory is supported by NIH grants R21DK114652 and R21AG053592, a Challenge Grant from the Novo Nordisk Foundation (NNF202585), KAUST funding (OSR-2019-CRG8-URF/1/4042), and via access to the Genomics High Throughput Facility Shared Resource of the Cancer Center Support Grant (CA-62203) and the UCI and NIH-shared instrumentation grants 1S10RR025496-01, 1S10OD010794-01, and 1S10OD021718-01.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Metabolic rewiring induced by ranolazine improves melanoma responses to targeted therapy and immunotherapy

  • Redondo Muñoz, Marta
  • Heyn, Holger
  • Arozarena, Imanol
Resistance of melanoma to targeted therapy and immunotherapy is linked to metabolic rewiring. Here, we show that increased fatty acid oxidation (FAO) during prolonged BRAF inhibitor (BRAFi) treatment contributes to acquired therapy resistance in mice. Targeting FAO using the US Food and Drug Administration-approved and European Medicines Agency-approved anti-anginal drug ranolazine (RANO) delays tumour recurrence with acquired BRAFi resistance. Single-cell RNA-sequencing analysis reveals that RANO diminishes the abundance of the therapy-resistant NGFRhi neural crest stem cell subpopulation. Moreover, by rewiring the methionine salvage pathway, RANO enhances melanoma immunogenicity through increased antigen presentation and interferon signalling. Combination of RANO with anti-PD-L1 antibodies strongly improves survival by increasing antitumour immune responses. Altogether, we show that RANO increases the efficacy of targeted melanoma therapy through its effects on FAO and the methionine salvage pathway. Importantly, our study suggests that RANO could sensitize BRAFi-resistant tumours to immunotherapy. Since RANO has very mild side-effects, it might constitute a therapeutic option to improve the two main strategies currently used to treat metastatic melanoma., I.A., P.A., D.E. and A.M. acknowledge funding from the Ministry of Economy and Competitiveness (Institute of Health Carlos III; refs. PI19/00645 to I.A., PI16-01911 to I.A., CPII20/00011 to I.A., CD21/00137 to P.A., PI20/00010 to D.E., PI20/00419 to D.E, PI19/01355 to A.M.). I.A. is also funded by Departamento de Salud del Gobierno de Navarra, Spain (ref. G°Na 71/17) D.A. acknowledges funding from The Spanish Association against Cancer (AECC; PROYE16001ESCO), Biomedicine Project Grant from the Department of Health of the Government of Navarre-FEDER funds (BMED 050-2019, 51-2021) and Strategic projects from the Department of Industry, Government of Navarre (AGATA, ref. 0011-1411; LINTERNA, ref. 0011–1411; DESCARTHES, 0011-1411-2019-000058). M.R.-M. is funded by a PhD studentship from the Department of Industry of the Government of Navarra, Spain and by the Grupo Español Multidisciplinar de Melanoma. The University of Colorado School of Medicine Metabolomics Core is supported in part by the University of Colorado Cancer Center award from the National Cancer Institute P30CA046934. Research in the S.A.B. laboratory is supported partially by the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement no. 787041), the Government of Cataluña (SGR grant), the Government of Spain (MINECO), the La Marató/TV3 Foundation, the Foundation Lilliane Bettencourt, the Spanish Association for Cancer Research (AECC) and the Worldwide Cancer Research Foundation (WCRF).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Targeting lymphoid-derived IL-17 signaling to delay skin aging

  • Solá, Paloma|||0000-0003-1554-0344
  • Mereu, Elisabetta|||0000-0001-6101-8472
  • Bonjoch, Júlia
  • Casado Pelaez, Marta|||0000-0002-8428-8384
  • Prats, Neus
  • Aguilera Pujabet, Mònica|||0000-0003-0763-7947
  • Reina, Oscar
  • Blanco, Enrique|||0000-0001-6261-7370
  • Esteller, M.|||0000-0003-4490-6093
  • Di Croce, Luciano|||0000-0003-3488-6228
  • Heyn, Holger|||0000-0002-3276-1889
  • Solanas, Guiomar|||0000-0001-8388-8647
  • Benitah, Salvador Aznar
Skin aging is characterized by structural and functional changes that contribute to age-associated frailty. This probably depends on synergy between alterations in the local niche and stem cell-intrinsic changes, underscored by proinflammatory microenvironments that drive pleotropic changes. The nature of these age-associated inflammatory cues, or how they affect tissue aging, is unknown. Based on single-cell RNA sequencing of the dermal compartment of mouse skin, we show a skew towards an IL-17-expressing phenotype of T helper cells, γδ T cells and innate lymphoid cells in aged skin. Importantly, in vivo blockade of IL-17 signaling during aging reduces the proinflammatory state of the skin, delaying the appearance of age-related traits. Mechanistically, aberrant IL-17 signals through NF-κB in epidermal cells to impair homeostatic functions while promoting an inflammatory state. Our results indicate that aged skin shows signs of chronic inflammation and that increased IL-17 signaling could be targeted to prevent age-associated skin ailments.